<DOC>
	<DOCNO>NCT02605538</DOCNO>
	<brief_summary>CF patient risk hepatic disease . Vaccination recommend CF patient accord European consensus . The aim study vaccinate many patient possible follow whether immunization complete .</brief_summary>
	<brief_title>Hepatitis B Cystic Fibrosis Latent Tuberculosis Respectively</brief_title>
	<detailed_description>Initially , healthy volunteer vaccinate compare patient ' antibody response hepatitis A B vaccine . The connected part study vaccinate child suffer latent tuberculosis hepatitis B measure whether immunization relate specific interferon gamma response Mycobacterium tuberculosis .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Latent Tuberculosis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>CF patient previously immunize hepatitis A B Healthy volunteer previously immunize hepatitis A B Age 1 year Previously transplant patient Previous vaccination hepatitis vaccine Known allergy component Twinrix ( TM )</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>